标题
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
作者
关键词
-
出版物
Cancers
Volume 11, Issue 7, Pages 971
出版商
MDPI AG
发表日期
2019-07-11
DOI
10.3390/cancers11070971
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- HER2 CAR-T cells eradicate uveal melanoma and T cell therapy-resistant human melanoma in interleukin-2 (IL-2) transgenic NOD/SCID IL-2 receptor knockout mice
- (2019) Elin MV Forsberg et al. CANCER RESEARCH
- Overall survival after treatment for metastatic uveal melanoma
- (2019) Elina S. Rantala et al. MELANOMA RESEARCH
- Response to Anti–PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis
- (2019) Douglas B. Johnson et al. Journal of the National Comprehensive Cancer Network
- Clinical predictors of survival in metastatic uveal melanoma
- (2019) Daniel Lorenzo et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
- (2019) L Khoja et al. ANNALS OF ONCOLOGY
- Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients
- (2018) Bertil Damato et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
- (2018) A. Gordon Robertson et al. CANCER CELL
- Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
- (2018) Richard D. Carvajal et al. JOURNAL OF CLINICAL ONCOLOGY
- New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma
- (2018) Christopher A. Barker et al. Journal of the National Comprehensive Cancer Network
- Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death – A personal view
- (2018) Bertil Damato PROGRESS IN RETINAL AND EYE RESEARCH
- Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells
- (2018) Felix S. Lichtenegger et al. Frontiers in Immunology
- The Pharmacology of T Cell Therapies
- (2018) Michael C. Milone et al. Molecular Therapy-Methods & Clinical Development
- Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation
- (2018) Valesca P. Retèl et al. BMC CANCER
- Prognostication of metastatic death in uveal melanoma patients: A Markov multi-state model
- (2018) Antonio Eleuteri et al. COMPUTERS IN BIOLOGY AND MEDICINE
- An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
- (2018) Jane Harper et al. PLoS One
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- TIM-3, a promising target for cancer immunotherapy
- (2018) Yayi He et al. OncoTargets and Therapy
- Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells
- (2017) Caroline Boudousquie et al. IMMUNOLOGY
- PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma
- (2017) Asad Javed et al. Immunotherapy
- Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease
- (2017) Ioannis Karydis et al. JOURNAL OF SURGICAL ONCOLOGY
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
- (2017) Smita S Chandran et al. LANCET ONCOLOGY
- Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma
- (2017) Vivian Chua et al. MOLECULAR CANCER RESEARCH
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity
- (2017) Matthias P. Domogalla et al. Frontiers in Immunology
- Metastatic disease from uveal melanoma: treatment options and future prospects
- (2016) Richard D Carvajal et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies
- (2016) Alain P. Algazi et al. CANCER
- Rationale for anti-GITR cancer immunotherapy
- (2016) Deborah A. Knee et al. EUROPEAN JOURNAL OF CANCER
- Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials
- (2016) Seongseok Yun et al. Cancer Medicine
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- ImmTACs for targeted cancer therapy: Why, what, how, and which
- (2015) Joanne Oates et al. MOLECULAR IMMUNOLOGY
- iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
- (2015) John W. Crabb et al. PLoS One
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
- (2014) S. Leyvraz et al. ANNALS OF ONCOLOGY
- ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells
- (2014) Giovanna Bossi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells
- (2014) Giovanna Bossi et al. OncoImmunology
- Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells
- (2013) M M van Loenen et al. GENE THERAPY
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
- (2013) Andrew M. Intlekofer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection
- (2013) D. Gomez et al. JOURNAL OF SURGICAL ONCOLOGY
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
- (2013) Jennifer D. Stone et al. Frontiers in Immunology
- MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
- (2012) Ernie Marshall et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture
- (2012) B Damato EYE
- Radiotherapy for ocular tumours
- (2012) C Stannard et al. EYE
- Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET ONCOLOGY
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- T-Cell Tolerance: Central and Peripheral
- (2012) Y. Xing et al. Cold Spring Harbor Perspectives in Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- 9304 ORAL Percutaneous Hepatic Perfusion (PHP) Vs. Best Alternative Care (BAC) for Patients (pts) With Melanoma Liver Metastases – Efficacy Update of the Phase 3 Trial (NCT00324727)
- (2011) J.F. Pinqpank et al. EUROPEAN JOURNAL OF CANCER
- Differences in uveal melanomas between men and women from the British Isles
- (2011) B E Damato et al. EYE
- Science gone translational: the OX40 agonist story
- (2011) Andrew D. Weinberg et al. IMMUNOLOGICAL REVIEWS
- Uveal Melanoma: Trends in Incidence, Treatment, and Survival
- (2011) Arun D. Singh et al. OPHTHALMOLOGY
- Estimating prognosis for survival after treatment of choroidal melanoma
- (2011) Bertil Damato et al. PROGRESS IN RETINAL AND EYE RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started